Methodological Hurdles in Conducting Pharmacoeconomic Analyses
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 15 (4) , 339-355
- https://doi.org/10.2165/00019053-199915040-00002
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- Methods for Comparing the Means of Two Independent Log-Normal SamplesPublished by JSTOR ,1997
- Some imperatives for clinical research.1997
- The role of economic evaluation in the pricing and reimbursement of medicinesHealth Policy, 1997
- The review process used by U.S. health care plans to evaluate new medical technology for coverageJournal of General Internal Medicine, 1996
- The Role of Perspective in Defining Economic Measures for the Evaluation of Medical TechnologyInternational Journal of Technology Assessment in Health Care, 1996
- The clinical-economic trial: Promise, problems, and challengesControlled Clinical Trials, 1995
- Economic analysis during phase III clinical trials: who, what, when, where, and why?1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994